Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    9:00 AM - 10:00 AM Central Time
    26S10: The Emerging Adult with JIA: What Adult Rheumatologists Need to Know
    Location: W181A-C
    Moderator: Sarah D. Bayefsky, MD – Hackensack University Medical Center
    Moderator: Amanda Moyer, MD – Oklahoma University (OU) Health & the Oklahoma Medical Research Foundation (OMRF)
    Session Coordinator: Sarah D. Bayefsky, MD – Hackensack University Medical Center
     CE: 1
  • Sunday, Oct 26th
    9:00 AM - 10:00 AM Central Time
    26S16: Go CAR-Ting and Beyond for Kids: State of the Art of Pediatric Cell-Based Therapies
    Location: W475A-B
    Moderator: Shaun Jackson, MD, PhD – Seattle Children's Research Institute
    Moderator: Holly Wobma, MD;PhD – Boston Children's Hospital
    Session Coordinator: Susan Shenoi, MS, MBBS, RhMSUS – Seattle Children's Hospital and Research Center
    Session Coordinator: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
     CE: 1
  • Sunday, Oct 26th
    9:00 AM - 9:30 AM Central Time
    Key Insights on Adult Rheumatologists' Management of Juvenile Idiopathic Arthritis: A Pediatric Rheumatologist's Perspective
    Location: W181A-C
    Speaker: Evelyn Rozenblyum, MD, FRCPC – Women's College Hospital
     CE: 1
  • Sunday, Oct 26th
    9:00 AM - 10:00 AM Central Time
    State of the Art: Pediatric Cell-Based Therapies
    Location: W475A-B
    Speaker: Georg Schett, MD – Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
     CE: 1
  • Sunday, Oct 26th
    9:30 AM - 10:00 AM Central Time
    Key Insights on Adult Rheumatologists' Management of Juvenile Idiopathic Arthritis: An Adult Rheumatologist's Perspective
    Location: W181A-C
    Speaker: Natasha Gakhal, MD – WCH
     CE: 1
  • Sunday, Oct 26th
    9:00 AM - 10:30 AM Central Time
    26S03: Juvenile Dermatomyositis: Updates in Current Medical, Physical, and Occupational Therapy Treatment
    Location: W184A
    Moderator: Veronica Lewalski, MD – Children's Hospital Los Angeles
    Moderator: Janet Bahr, NP – Family Neighborhood Clinic
    Session Coordinator: Janet Bahr, NP – Family Neighborhood Clinic
     CE: 1.5
  • Sunday, Oct 26th
    9:00 AM - 9:30 AM Central Time
    Juvenile Dermatomyositis: The Medical Perspective
    Location: W184A
    Speaker: Jacob Spitznagle, MD – Children's Hospital Los Angeles
     CE: 1.5
  • Sunday, Oct 26th
    9:30 AM - 10:00 AM Central Time
    Juvenile Dermatomyositis: Physical Therapy Perspective
    Location: W184A
    Speaker: Jill Blitz, PT – Children's Hospital Los Angeles
     CE: 1.5
  • Sunday, Oct 26th
    10:00 AM - 10:30 AM Central Time
    Juvenile Dermatomyositis: Occupational Therapy Perspective
    Location: W184A
    Speaker: Talitha Black, OT, MA – Children's Hospital Los Angeles
     CE: 1.5
  • Sunday, Oct 26th
    10:00 AM - 11:00 AM Central Time
    NL26S3: Pediatric Rheumatology Journal Meet the Editors
    Location: W470B
    Lead Facilitator: Susan Shenoi, MS, MBBS, RhMSUS – Seattle Children's Hospital and Research Center
    Lead Facilitator: Angelo Ravelli, MD – IRCCS Istituto Giannina Gaslini, Genoa, Italy
    Lead Facilitator: Tadej Avcin, MD, PhD – University Children's Hospital, University Medical Center Ljubljana
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 11:30 AM Central Time
    26S27: Joint Ventures: Unraveling the Rheum - Gut Axis Through Interactive Pediatric Cases
    Location: W185A-D
    Moderator: Sivia Lapidus, MD – Hackensack University Medical Center
    Moderator: Adam Mayer, MD – Hackensack University Medical Center
    Session Coordinator: Sivia Lapidus, MD – Hackensack University Medical Center
     CE: 1
  • Sunday, Oct 26th
    10:30 AM - 11:00 AM Central Time
    Gut Bone Axis: Immune Dysregulation Case
    Location: W185A-D
    Interactive Speaker: Melissa Argraves, MD, MEd – Nationwide Children's Hospital
     CE: 1
  • Sunday, Oct 26th
    11:00 AM - 11:30 AM Central Time
    Extra-Intestinal Manifestation of Inflammatory Bowel Disease Case
    Location: W185A-D
    Speaker: Elizabeth Spencer, MD, MSc – Icahn School of Medicine at Mount Sinai
     CE: 1
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Pediatric Rheumatology – Clinical Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    (TM01–TM11) Pediatric Thieves Market Poster
    Location: Hall F1
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0408: Implementing Social Drivers of Health Screening for Patients with Pediatric Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0423: Macrophage activation syndrome-associated proteins and enhanced interferon gamma responsiveness characterize the plasma proteome of patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in a pre-treatment replication single center cohort
    Location: Hall F1
    Abstract Poster Presenter: Sarah McCuaig, MD, PhD (she/her/hers) – Children's Hospital of Philadelphia
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM01: A Case of Progressive Hand Deformities
    Location: Hall F1
    Thieves Market Poster Presenter: Anjali Sura, MD – SUNY Upstate
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM02: A Girl with Golden Lesions
    Location: Hall F1
    Thieves Market Poster Presenter: Dania Aldajeh, MD – Texas Tech El Paso
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM03: Always Check Your Pockets
    Location: Hall F1
    Thieves Market Poster Presenter: Nicholas Blair, MD – Emory University
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM04: An Ear-ie Clue: When a Wheeze Isn't Just Asthma
    Location: Hall F1
    Thieves Market Poster Presenter: Veronica Lewalski, MD – Children's Hospital Los Angeles
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM05: From Feline Bite To Systemic Strife: When the Obvious Isn’t the Answer
    Location: Hall F1
    Thieves Market Poster Presenter: Giuliana Colombari Arce, MD – Woodhull
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM06: HEADSS Up
    Location: Hall F1
    Thieves Market Poster Presenter: Carla Levin, MD, MS – Children’s Hospital of Colorado
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM07: Out of Sight, Out of Sound, Out of Mind
    Location: Hall F1
    Thieves Market Poster Presenter: Haeja Kessler, MD (she/her/hers) – Cincinnati Children's Hospital
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM08: The Great Infiltration
    Location: Hall F1
    Thieves Market Poster Presenter: Elizabeth Murray, MD – Nationwide Children's Hospital/The Ohio State University
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM09: The MAS-querade: Unraveling a Case of Misleading Inflammation
    Location: Hall F1
    Thieves Market Poster Presenter: Veronica Torres, PA-C – UT Southwestern Medical Center
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM10: The Muscle Enigma: A Diagnosis That Took a Detour
    Location: Hall F1
    Thieves Market Poster Presenter: Gollakota Nandita, MBBS/MD – NIMS, Hyderabad
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    TM11: A Glitch in the System
    Location: Hall F1
    Thieves Market Poster Presenter: Christina Gulla, DO – Hackensack University Medical Center
     CE: 0
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0393: Effects of Self-Reported Medication Barriers on Medication Adherence and Disease Activity in a Cohort of Patients with Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Aditi Shaily, MD (she/her/hers) – UBMD
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0392: Clinical Indicators of Methotrexate Response in Juvenile Idiopathic Arthritis (JIA) and JIA with Uveitis (JIA-U)
    Location: Hall F1
    Abstract Poster Presenter: Abigale Jagger, DO (she/her/hers) – Cincinnati Children's
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0409: Discordance Between Disease Activity and Patient-Reported Outcomes in Patients with Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0410: Improving Outcomes in Patients with Juvenile Idiopathic Arthritis through a Novel Chronic Condition Value-Based Care Program
    Location: Hall F1
    Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0411: Outcomes in Juvenile Idiopathic Arthritis Based on Geographic Region in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry
    Location: Hall F1
    Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0426: Tofacitinib in Juvenile Idiopathic Arthritis: efficacy and safety in a clinical practice setting.
    Location: Hall F1
    Abstract Poster Presenter: Vicenç Torrente-Segarra, PhD (he/him/his) – Hospital Comarcal Alt Penedés Garraf
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0389: An International Delphi Survey for the Definition of New Classification Criteria for Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Nicolino Ruperto, MD, MPH – Università Milano Bicocca and Fondazione IRCSS S. Gerardo dei Tintori
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0401: Longitudinal Effectiveness of Abatacept in JIA: Results From an Ongoing JIA Registry
    Location: Hall F1
    Abstract Poster Presenter: Daniel Lovell, MD, MPH – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0415: The Impact of Social Vulnerability Index Scores in Pediatric Uveitis
    Location: Hall F1
    Abstract Poster Presenter: Minal Aundhia, MD – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0396: Quantifying Burden of Uveitis Care for Pediatric Uveitis Patients and Caregivers
    Location: Hall F1
    Abstract Poster Presenter: Catherine Lavallee, MD – St. Christopher's Hospital for Children
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0398: Efficacy of Tumor Necrosis Factor Inhibitors in Children Diagnosed With Non-Systemic Juvenile Idiopathic Arthritis ≤ 2 Years Old Using The Childhood Arthritis and Rheumatology Research Alliance Registry
    Location: Hall F1
    Abstract Poster Presenter: Christina Gulla, DO – Hackensack University Medical Center
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0427: Maternal Smoking During Pregnancy and Risk of Juvenile Idiopathic Arthritis (JIA): Triangulating Evidence from Polygenic Risk Scores and Meta-Analysis in Scandinavian Birth Cohorts
    Location: Hall F1
    Abstract Poster Presenter: Vilde Øverlien Dåstøl, MD – Oslo University Hospital
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0412: The Association of Obesity with Juvenile Spondyloarthritis
    Location: Hall F1
    Abstract Poster Presenter: Katelyn Baggett, MD – Johns Hopkins University
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0406: Comparing biomarkers associated with uveitis in tear fluid and serum samples of children with Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Ilaria Maccora, MD, PhD (she/her/hers) – Rheumatology Unit, ERN ReCoNNET Center, Meyer Children's Hospital IRCCS, Florence, Italy
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0407: The SOS project: to Switch Or to Swap After Adalimumab failure for the management of childhood non-infectious uveitis in an international cohort
    Location: Hall F1
    Abstract Poster Presenter: Ilaria Maccora, MD, PhD (she/her/hers) – Rheumatology Unit, ERN ReCoNNET Center, Meyer Children's Hospital IRCCS, Florence, Italy
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0390: Radiographic Assessment in Juvenile Spondyloarthritis: Evaluating the axJSpA Criteria Using Radiographs Alone Versus MRI
    Location: Hall F1
    Abstract Poster Presenter: Pamela Weiss, MD – Childrens Hospital of Philadelphia
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0391: Which score fits best? Correlation of clinical indices of Disease Activity and Ultrasound findings in Juvenile Idiopathic Arthritis during Transitional Care
    Location: Hall F1
    Abstract Poster Presenter: Silvia Magni-Manzoni, MD – Bambino Gesù IRCCS Children's Hospital
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0402: Risk Factors for Anti-Adalimumab Antibody Development in Pediatric Patients Using Adalimumab for Rheumatic Disease and Associated Conditions
    Location: Hall F1
    Abstract Poster Presenter: Dawn Gist, MD (she/her/hers) – Baylor College of Medicine Pediatric Rheumatology
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0413: Improving Access to Timely Joint Injections for Pediatric Rheumatology Patients – A Quality Improvement Initiative
    Location: Hall F1
    Abstract Poster Presenter: Kendra Lauer, DO – UT Southwestern
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0388: A Scoping Review of Outcomes of Adults with Childhood-onset Systemic Autoimmune Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Kaien Gu, MD, FRCPC – Feinstein Institutes for Medical Research
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0425: High Density Lipoprotein Dysfunction in Juvenile Idiopathic Arthritis as Compared to Children without Rheumatologic Disease
    Location: Hall F1
    Abstract Poster Presenter: Tahnee Spoden, MD (she/her/hers) – UCLA
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0424: Juvenile Idiopathic Arthritis Mimics: A Case Series on Progressive Pseudo-Rheumatoid Dysplasia and CACP Syndrome in Pediatric Patients from a Tertiary Center in South India
    Location: Hall F1
    Abstract Poster Presenter: Sreelekha Kambhampati, MD – Nizams institute of medical sciences
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0405: Juvenile Psoriatic Arthritis and Enthesitis-Related Arthritis: 4-Year Results From the JUNIPERA Extension Study
    Location: Hall F1
    Abstract Poster Presenter: Hermine Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0418: Evaluation of Disease Activity in the Knee Joint Through Clinical, Radiologic, Synovial Fluid and Histopathologic Measurements of Inflammation in Children with Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Patricia Vega-Fernandez, MD, RhMSUS, MSc – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0414: Predicting JIA-Associated Uveitis Using Tear Fluid Biomarkers: A Prospective Multicenter Study
    Location: Hall F1
    Abstract Poster Presenter: Mariia Pavlenko, MD – University of Colorado
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0397: Paediatric uveitis - Retrospective comparison of cataract surgery outcomes with or without intraocular lens implantation from two tertiary centres in United Kingdom
    Location: Hall F1
    Abstract Poster Presenter: Chaitra Govardhan, MBBS, MRCP – Bristol Royal Hospital for Children
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0421: Inflammatory Orbital Diseases: Pediatric Case Series From a Tertiary Care Center
    Location: Hall F1
    Abstract Poster Presenter: Rasha Elrefai, MD – Baylor College of Medicine
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0387: Association Between Juvenile Arthritis and Physical Activity Levels in U.S. Children: A Cross-sectional Study Using the 2016–2021 National Survey of Children’s Health
    Location: Hall F1
    Abstract Poster Presenter: Carolina Tamashiro, MD (she/her/hers) – UCSF
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0416: Outcomes Of Children with Juvenile Idiopathic Arthritis Receiving Biological Disease-Modifying Anti-Rheumatic Drugs: Retrospective Analysis of A Real-World Experience From A Resource-Limited Setting
    Location: Hall F1
    Abstract Poster Presenter: Narendra Bagri, MD (he/him/his) – All India Institute of Medical Sciences(AIIMS)
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0404: Disease Extension in Children with Limited Juvenile Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
    Location: Hall F1
    Abstract Poster Presenter: Eveline Wu, MD, MSc – UNC Chapel Hill
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0395: Association Between Body Mass Index (BMI) and JIA Inactive Disease at One Year
    Location: Hall F1
    Abstract Poster Presenter: Anna Sutton, MPH (she/her/hers) – University of Washington
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0428: The OMERACT Juvenile Idiopathic Arthritis MRI Score for Active and Structural Lesions in the Sacroiliac Joints: Development and Validation in Two Longitudinal Cohorts
    Location: Hall F1
    Abstract Poster Presenter: Walter P P. Maksymowych, MD, FRCPC, MRCP, FACP – University of Alberta
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0394: Predictors of quality of Life in a longitudinal cohort of patients with Uveitis, Juvenile Idiopathic Arthritis, and JIA-associated uveitis
    Location: Hall F1
    Abstract Poster Presenter: Andressa Guariento Alves, MD, PhD – The Childrens Hospital of Philadelphia
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0422: Clinical Outcomes of Ultrasound Guidance for Corticosteroid Injections of the Ankle and Midfoot Joints and Tendon Sheaths in Children with Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Rina Ferguson, MD, MBA (she/her/hers) – Seattle Children's Hospital
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0429: Real-world experience of upadacitinib therapy in difficult-to-treat juvenile idiopathic arthritis: a case series of 24 patients
    Location: Hall F1
    Abstract Poster Presenter: Xuemei Tang, MD, Professor, Chief Physician – Department of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0419: Ultrasound-Guided Synovial Biopsy in Children and Adolescents with Juvenile Arthritis: Initial Results
    Location: Hall F1
    Abstract Poster Presenter: Patricia Vega-Fernandez, MD, RhMSUS, MSc – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0417: Implementation of a Communication Aid in Juvenile Idiopathic Arthritis Patient Visits, a Quality Improvement Study
    Location: Hall F1
    Abstract Poster Presenter: Nazlican Civilibal Tang, MD (she/her/hers) – washu pediatric rheumatology
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0420: Long-term efficacy of intra-articular triamcinolone hexacetonide injections in juvenile idiopathic arthritis patients starting tumor necrosis factor inhibitor therapy: 48 weeks results from a randomized, open-label, blinded-assessor multicenter phase 4 trial - the MyJIA trial
    Location: Hall F1
    Abstract Poster Presenter: Pernille Bøyesen, MD, PhD – Oslo University Hospital
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0403: IL-6 as a Predictor of Response to Olokizumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Results of the Phase 2 Clinical Trial
    Location: Hall F1
    Abstract Poster Presenter: Ekaterina Alexeeva, MD, PhD – National Medical Research Center for Children’s Health Federal State Autonomous Institution of the Russian Federation Ministry of Health and I.M. Sechenov First Moscow State Medical University (Sechenovskiy University)
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0399: External Validation of Claims-based Algorithms for Newly Diagnosed Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0400: Recent Antibiotic Exposure and Response to Treatment of Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
     CE: 0.00
  • Sunday, Oct 26th
    2:30 PM - 3:30 PM Central Time
    26S48: Endothelial Insights: Mechanisms and Biomarkers of Vasculopathy in Juvenile Dermatomyositis
    Location: W471B
    Moderator: Sara Sabbagh, DO – Medical College of Wisconsin
    Moderator: Lauren Covert, MD – Duke University School of Medicine
    Moderator: Lisa G. Rider, MD – NIEHS, NIH
    Session Coordinator: Jessica Neely, MD – UCSF
     CE: 1
  • Sunday, Oct 26th
    2:30 PM - 3:00 PM Central Time
    Endothelial Dysfunction in Juvenile Dermatomyositis
    Location: W471B
    Speaker: Jessica Turnier, MD, MS – University of Michigan
     CE: 1
  • Sunday, Oct 26th
    3:00 PM - 3:30 PM Central Time
    Juvenile Dermatomyositis Vasculopathy: Emerging Biomarkers
    Location: W471B
    Speaker: Femke van Wijk, PhD – University Medical Centre Utrecht
     CE: 1
  • Sunday, Oct 26th
    3:00 PM - 4:30 PM Central Time
    26S54: Abstracts: Pediatric Rheumatology – Basic Science
    Location: W183A-C
    Abstract Moderator: Anna Patrick, MD, PhD – Vanderbilt University Medical Center
    Abstract Moderator: Margaret Chang, MD, PhD – Boston Children's Hospital
     CE: 0.00
  • Sunday, Oct 26th
    3:00 PM - 3:15 PM Central Time
    0819: Subcellular resolution spatial transcriptomics reveals immune-stromal crosstalk within the synovium of patients with juvenile idiopathic arthritis
    Location: W183A-C
    Presenting Author: Jun Inamo, MD, PhD – University of Colorado School of Medicine
     CE: 0.00
  • Sunday, Oct 26th
    3:15 PM - 3:30 PM Central Time
    0820: Novel Autoantibodies Predictive of Atherosclerosis Progression and Statin Response in Juvenile-Onset Systemic Lupus Erythematosus
    Location: W183A-C
    Presenting Author: Coziana Ciurtin, MD, PhD, FRCP – University College London
     CE: 0.00
  • Sunday, Oct 26th
    3:30 PM - 3:45 PM Central Time
    0821: Flipping The Switch – Classical Complement Activation closely linked to IFN-signalling in Stills Disease
    Location: W183A-C
    Presenting Author: Freya Huijsmans, MD, MSc – UMC Utrecht, Wilhelmina Children's Hospital
     CE: 0.00
  • Sunday, Oct 26th
    3:45 PM - 4:00 PM Central Time
    0822: Clinical and Mechanistic Insight of Circulating Calprotectin and NXP2 autoantibodies in Juvenile Dermatomyositis
    Location: W183A-C
    Presenting Author: Kavya Sugur, PhD – Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor
     CE: 0.00
  • Sunday, Oct 26th
    4:00 PM - 4:15 PM Central Time
    0823: Longitudinal model of paired peripheral blood CITE-seq and skin scRNA-seq data in juvenile systemic sclerosis (jSSc) patients following autologous stem cell transplant (ASCT) reveals reduced expression of SSc marker genes
    Location: W183A-C
    Presenting Author: Julia Elrod, MS – Carnegie Mellon University
     CE: 0.00
  • Sunday, Oct 26th
    4:15 PM - 4:30 PM Central Time
    0824: Characterizing Immune Responses in Abatacept-treated Patients with Limited Juvenile Idiopathic Arthritis
    Location: W183A-C
    Presenting Author: Lwiza AitDowd, BS – Boston Children's Hospital, Harvard Medical School
     CE: 0.00
  • Monday, Oct 27th
    8:30 AM - 9:30 AM Central Time
    27M12: Beneath the Surface: Expert Medical and Surgical Approaches to Difficult Cases in Juvenile Localized Scleroderma
    Location: W185A-D
    Moderator: Ivan Foeldvari, MD – Hamburger Zentrum für Kinder- und Jugendrheumatologie
    Moderator: Natalia Vasquez Canizares, MD, MS – Children's Hospital at Montefiore
    Session Coordinator: Jaime Guzman, MD, MSc – University of British Columbia and BC Children's Hospital
     CE: 1
  • Monday, Oct 27th
    8:30 AM - 9:30 AM Central Time
    27M13: FIRED UP: Immune Dysregulation in the Central Nervous System
    Location: W471B
    Moderator: Joseph McDonald, MD, RhMSUS – University of Chicago
    Session Coordinator: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
    moderator: Stephen Wong, MD – University of Washington/Seattle Children's Hospital
     CE: 1
  • Monday, Oct 27th
    8:30 AM - 9:30 AM Central Time
    NL27M1: Pediatrics: ACR Peds Committee: AMIGO
    Location: W470A
    Lead Facilitator: Leandra Woolnough, MD – University of Florida
    Lead Facilitator: Erin Treemarcki, DO – Department of Pediatrics, Division of Pediatric Rheumatology, University of Utah
     CE: 0
  • Monday, Oct 27th
    8:30 AM - 9:00 AM Central Time
    Challenges in the Medical Managemennt of Juvenile Localized Scleroderma
    Location: W185A-D
    Interactive Speaker: Suzanne Li, MD, PhD – Joseph M. Sanzari Children's Hospital, Hackensack Meridian SOM
     CE: 1
  • Monday, Oct 27th
    8:30 AM - 9:00 AM Central Time
    FIRES: Immunopathology and Treatment
    Location: W471B
    Speaker: Eyal Muscal, MD, MS – Baylor College of Medicine
     CE: 1
  • Monday, Oct 27th
    9:00 AM - 9:30 AM Central Time
    Challenges in the Surgical Management of Juvenile Localized Scleroderma
    Location: W185A-D
    Interactive Speaker: Ingrid Ganske, MD – Boston Children's Hospital
     CE: 1
  • Monday, Oct 27th
    9:00 AM - 9:30 AM Central Time
    Isolated Primary CNS HLH: Immunopathogenesis and Treatment Considerations
    Location: W471B
    Speaker: Lauren Henderson, MD;MSc – Boston Children's Hospital
     CE: 1
  • Monday, Oct 27th
    10:00 AM - 11:00 AM Central Time
    NL27M3: Pediatrics: Peds AMPC/ACR Peds Committee: Idea Incubator
    Location: W470B
    Lead Facilitator: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
    Lead Facilitator: Linda Hiraki, MD, FRCPC, ScD – The Hospital for Sick Children
    Lead Facilitator: Sivia Lapidus, MD – Hackensack University Medical Center
     CE: 0
  • Monday, Oct 27th
    10:00 AM - 11:30 AM Central Time
    27M29: Toward a Cure for Childhood Arthritis
    Location: W471B
    Moderator: Marinka Twilt, MD, PhD, MSc – Alberta Children's Hospital
    Moderator: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
    Session Coordinator: Jaime Guzman, MD, MSc – University of British Columbia and BC Children's Hospital
     CE: 1.5
  • Monday, Oct 27th
    10:00 AM - 10:30 AM Central Time
    Understanding and Harnessing the Biology of Childhood Arthritis
    Location: W471B
    Speaker: Rae Yeung, MD, PhD – The Hospital for Sick Children, University of Toronto
     CE: 1.5
  • Monday, Oct 27th
    10:30 AM - 11:00 AM Central Time
    Care Transformation in Childhood Arthritis via Precision Medicine
    Location: W471B
    Speaker: Sebastiaan Vastert, MD, PhD – University Medical Center Utrecht
     CE: 1.5
  • Monday, Oct 27th
    11:00 AM - 11:30 AM Central Time
    Toward a Health Economic Value Framework for Childhood Arthritis
    Location: W471B
    Speaker: Deborah Marshall, PhD – University of Calgary
     CE: 1.5
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Pediatric Rheumatology – Clinical Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1273: Effectiveness of IV Cyclophosphamide and Mycophenolate Mofetil in the Treatment of Pediatric Systemic Lupus Erythematosus with Lupus Nephritis
    Location: Hall F1
    Abstract Poster Presenter: Adrienne Katrin Guiang-Valerio, MD (she/her/hers) – University of Santo Tomas Hospital
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1274: Analysis of Vaccination Compliance in Patients with Juvenile Idiopathic Arthritis at the Rheumatology Transitional Consultation
    Location: Hall F1
    Abstract Poster Presenter: Andres Perez Hurtado, Sr, MD (he/him/his) – Hospital Universitario y Politécnico La Fe
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1275: Fostering connections in Pediatric Rheumatology: A Narrative medicine intervention
    Location: Hall F1
    Abstract Poster Presenter: Anita Dhanrajani, MBBS, MSc – Manning Family Children's Hospital, Tulane School of Medicine
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1276: Mental Health Screening Implementation for Pediatric Rheumatology Patients at a Tertiary Academic Medical Center
    Location: Hall F1
    Abstract Poster Presenter: Bethany Walker, CRNP – Childrens of Alabama
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1277: Combination Therapy with Rituximab and Cyclophosphamide for Treating Pediatric Patients with Severe Manifestations of Rheumatic Disease
    Location: Hall F1
    Abstract Poster Presenter: Eileen Rife, MD – University of Alabama Birmingham
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1278: Differences in Patient and Provider Perception of Functional Status in Adolescents with Lupus
    Location: Hall F1
    Abstract Poster Presenter: Emily Masi, MD, PhD – Cohen Children's Medical Center
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1279: Whole Blood Gene Expression Defined Subgroups of Treatment Naïve Children and Adolescents with Childhood-onset Systemic Lupus Erythematosus.
    Location: Hall F1
    Abstract Poster Presenter: Reagan Reid, MSc – University of Toronto
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1280: Investigating the Association Between SARS-CoV-2 Infection, COVID-19 Vaccination, and Autoimmune Diseases in a Pediatric Population: A comprehensive analysis
    Location: Hall F1
    Abstract Poster Presenter: Yonatan Butbul Aviel, MD (he/him/his) – Rambam Medical center
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1281: Ethnic Disparities in Mental Health Screening, Diagnoses, and Outcomes in Patients with Childhood-Onset Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Alicia Tran, BSc (she/her/hers) – University of Toronto
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1282: Real-world use of belimumab in childhood-onset SLE in Spain: cross-sectional analysis from a multicenter study (JULES registry)
    Location: Hall F1
    Abstract Poster Presenter: Alina Lucica Boteanu, MD – H.U. Ramón y Cajal
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1283: Impact of Guideline Concordant Care of Renal Outcomes in Childhood-Onset Lupus Nephritis
    Location: Hall F1
    Abstract Poster Presenter: Alisha Akinsete, MD – Weill Cornell Medical Center
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1284: Clinical implications of Antiphospholipid Antibodies and Secondary Antiphospholipid Syndrome in Juvenile-onset Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Daniel Clemente, MD,PhD – Hospital Niño Jesús
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1285: Investigating the Relationship Between Brain Injury Markers and Brain Volume in Children with Systemic Lupus Erythematosus and Healthy Controls
    Location: Hall F1
    Abstract Poster Presenter: Ganesh Ramanathan, -None- – The Hospital for Sick Children
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1286: Response to Hydroxychloroquine in Immune Thrombocytopenia in Childhood-Onset Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Hamada Natour, MD (he/him/his) – The Hospital for Sick Children, U of Toronto
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1287: A Clear Pattern of Clinical Presentation in Juvenile Systemic Scleroderma Is Associated with Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Ivan Foeldvari, MD – Hamburger Zentrum für Kinder- und Jugendrheumatologie
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1288: Is gastroesophageal reflux a risk for interstitial lung disease in Juvenile systemic sclerosis?
    Location: Hall F1
    Abstract Poster Presenter: Ivan Foeldvari, MD – Hamburger Zentrum für Kinder- und Jugendrheumatologie
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1289: Longitudinal Exploration of Pain and Disease Characteristics in Youth with Childhood-Onset Lupus
    Location: Hall F1
    Abstract Poster Presenter: Jida Jaffan, MA – The Hospital for Sick Children/ University of Toronto
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1290: Adverse Childhood Experiences: Prevalence and Relationship to Disease and Mental Health Outcomes in Childhood-onset Systemic Lupus Erythematosus (cSLE)
    Location: Hall F1
    Abstract Poster Presenter: Jin Xuan Zhou, BSc (she/her/hers) – The Hospital for Sick Children
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1291: Gastrointestinal Tract Involvement in Juvenile Systemic Sclerosis: Results from an International Scoping Review of Outcome Measures
    Location: Hall F1
    Abstract Poster Presenter: Lauren Robinson, MD (she/her/hers) – Hospital for Special Surgery
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1292: Childhood-onset Behçet's disease: HLA alleles role on diagnosis and treatment in a Latin American tertiary center
    Location: Hall F1
    Abstract Poster Presenter: Lucia Campos, MD, PhD (she/her/hers) – University of Sao Paulo Medical School
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1293: Synovitis and periarticular soft tissues abnormalities in childhood-onset systemic lupus erythematosus: an ultrasonography study
    Location: Hall F1
    Abstract Poster Presenter: Lucia Campos, MD, PhD (she/her/hers) – University of Sao Paulo Medical School
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1294: Implementation of Pneumococcal Vaccination in Patients with Childhood-Onset Systemic Lupus Erythematous
    Location: Hall F1
    Abstract Poster Presenter: Magan Fosso, n/a – UT Southwestern
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1295: Neuropsychiatric Lupus in Children and Adolescents: Understanding Current Practices and Barriers to Care Perceived by Pediatric Rheumatology Clinicians in North America
    Location: Hall F1
    Abstract Poster Presenter: Martha Rodriguez, MD – Riley Hospital For Children At Indiana University
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1296: Liver Biopsy Findings in Pediatric SLE: A Large Tertiary Center Experience
    Location: Hall F1
    Abstract Poster Presenter: Meredith Rae, MD (she/her/hers) – Baylor College of Medicine/Texas Children's
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1297: Biologic Therapy for Refractory Juvenile Scleroderma: a retrospective case-series from a single tertiary care center in Saudi Arabia.
    Location: Hall F1
    Abstract Poster Presenter: Munira Al Marri, Dr, MD (she/her/hers) – Prince Sultan Military Medical City
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1298: Identifying Psychosocial Profiles in Youth with Chronic Musculoskeletal Pain: A K-Means Clustering Analysis of Resilience Subgroups
    Location: Hall F1
    Abstract Poster Presenter: Nellie Butler, BA – Children's Hospital of Philadelphia
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1299: Pediatric Antiphospholipid Syndrome in a Large Tertiary Center
    Location: Hall F1
    Abstract Poster Presenter: Rasha Elrefai, MD – Baylor College of Medicine
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1300: International Assessment of cSLE Clinical Remission (cCR) Criteria in Childhood Lupus: Sensitivity Analyses from the UK JSLE Cohort and the CARRA Registry
    Location: Hall F1
    Abstract Poster Presenter: Rebecca Sadun, MD, PhD – Duke University
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1301: Prevalence, Clinical and Genetic Risk Factors, and Time to Cataract Development in Childhood-onset Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Sirikarn Tangcheewinsirikul, MD – The Hospital for Sick Children
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1302: Dose Adjustment was Necessary in Patients with Cryopyrin-Associated Periodic Syndrome Switching from Anakinra to Canakinumab
    Location: Hall F1
    Abstract Poster Presenter: Soyoung Lee, MD, PhD (she/her/hers) – Chung-Ang University Hospital
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1303: Impact of Fruits and Vegetables Intake on Immune-mediated Inflammatory Diseases：a Two-sample Mendelian Randomization Study
    Location: Hall F1
    Abstract Poster Presenter: Xuemei Tang, MD, Professor, Chief Physician – Department of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1304: The role of PET/CT in evaluating rheumatologic conditions in children with fever of unknown origin - a multicenter study
    Location: Hall F1
    Abstract Poster Presenter: YOEL Levinsky, MD – Schneider Children's Medical Cnetr of Israel, Tel Aviv University
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1305: Clinical outcomes of low-to-moderate–dose glucocorticoids in multisystem inflammatory syndrome in children (MIS-C) - a multicenter study
    Location: Hall F1
    Abstract Poster Presenter: YOEL Levinsky, MD – Schneider Children's Medical Cnetr of Israel, Tel Aviv University
     CE: 0.00
  • Monday, Oct 27th
    1:00 PM - 2:30 PM Central Time
    27M35: Abstracts: Pediatric Rheumatology – Clinical I
    Location: W183A-C
    Abstract Moderator: Pooja Patel, DO – Ann and Robert H. Lurie Children's Hospital of Chicago
    Abstract Moderator: Emily Smitherman, MD, MS – University of Alabama at Birmingham
     CE: 0.00
  • Monday, Oct 27th
    1:00 PM - 1:15 PM Central Time
    1668: A Clinically Validated Assay for Rapid Determination of Type I and Type II Interferon Activity in Pediatric Inflammatory Diseases
    Location: W183A-C
    Presenting Author: Pui Lee, MD, PhD – Boston Children's Hospital
     CE: 0.00
  • Monday, Oct 27th
    1:15 PM - 1:30 PM Central Time
    1669: Development and Validation of Minimal Disease Activity and Disease Flare for Children with Chronic Nonbacterial Osteomyelitis Using a Consensus and Data-Driven Approach
    Location: W183A-C
    Presenting Author: Farzana Nuruzzaman, MD – Stony Brook Children's Hospital
     CE: 0.00
  • Monday, Oct 27th
    1:30 PM - 1:45 PM Central Time
    1670: Large Retrospective Cohort Study Of Chronic Recurrent Multifocal Osteomyelitis: Disease Presentation, Clinical, And Laboratory Features
    Location: W183A-C
    Presenting Author: Shima Yasin, MD, MSc, FACR, FAAP – MNGHA
     CE: 0.00
  • Monday, Oct 27th
    1:45 PM - 2:00 PM Central Time
    1671: Emapalumab Treatment for Patients with Differing Presentations of Macrophage Activation Syndrome (MAS) Secondary to Still’s Disease: Results from a Pooled Analysis of Two Prospective Trials
    Location: W183A-C
    Presenting Author: Alexei Grom, MD – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Monday, Oct 27th
    2:00 PM - 2:15 PM Central Time
    1672: Classification criteria, disease phenotypes and long-term outcomes of childhood Sjögren's Disease into adulthood
    Location: W183A-C
    Presenting Author: Coziana Ciurtin, MD, PhD, FRCP – University College London
     CE: 0.00
  • Monday, Oct 27th
    2:15 PM - 2:30 PM Central Time
    1673: Is Transient Synovitis of the Hip preclinical Juvenile SpA ? A follow-up study
    Location: W183A-C
    Presenting Author: Anirudh Bandu, MD (he/him/his) – Nicklaus Childrens Hospital
     CE: 0.00
  • Monday, Oct 27th
    2:30 PM - 3:30 PM Central Time
    27M58: The Cytokine Language of Still's Disease and MAS
    Location: W471B
    Moderator: Lauren Henderson, MD;MSc – Boston Children's Hospital
    Moderator: Susan Canny, MD, PhD – Seattle Children's Hospital/University of Washington
    Session Coordinator: Pui Lee, MD, PhD – Boston Children's Hospital
     CE: 1
  • Monday, Oct 27th
    2:30 PM - 3:00 PM Central Time
    IL-18 as a Guide to the Evaluation and Management of Still's Disease
    Location: W471B
    Speaker: Scott Canna, MD – Children's Hospital of Philadelphia
     CE: 1
  • Monday, Oct 27th
    3:00 PM - 3:30 PM Central Time
    Biomarkers of Still's Disease and Macrophage Activation Syndrome
    Location: W471B
    Speaker: Alexei Grom, MD – Cincinnati Children's Hospital Medical Center
     CE: 1
  • Monday, Oct 27th
    4:00 PM - 5:00 PM Central Time
    27M73: Charting the Course for Next Generation Pediatric Lupus Therapies
    Location: W471B
    Moderator: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
    Moderator: Joyce Hui-Yuen, MD, MS – North Shore LIJ Health System
    Session Coordinator: Joyce Hui-Yuen, MD, MS – North Shore LIJ Health System
     CE: 1
  • Monday, Oct 27th
    4:00 PM - 4:30 PM Central Time
    Current Barriers to Medication Development in Pediatrics
    Location: W471B
    Speaker: Hermine Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center
     CE: 1
  • Monday, Oct 27th
    4:30 PM - 5:00 PM Central Time
    Role of Adult Lupus Trials in Supporting Pediatric Lupus Trials
    Location: W471B
    Speaker: Anca Askanase, MD, MPH – Columbia University Medical Center
     CE: 1
  • Tuesday, Oct 28th
    10:00 AM - 11:00 AM Central Time
    NL28T2: Pediatric Community in the ACR and ARP
    Location: W470A
    Lead Facilitator: Tracy Ting, MD, RhMSUS, MSc – Cincinnati Children's Hospital Medical Center
    Lead Facilitator: Brit Donaldson, MMS, PA-C – Atrium Health Wake Forest Baptist/Brenner Children's
    Lead Facilitator: Kristine Carandang, PhD, OT – Young Patients' Autoimmune Research & Empowerment Alliance
     CE: 0
  • Tuesday, Oct 28th
    10:00 AM - 11:30 AM Central Time
    28T17: Abstracts: Pediatric Rheumatology – Clinical II
    Location: W196A-C
    Abstract Moderator: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
    Abstract Moderator: Sampath Prahalad, MD, MSc – Emory + Children's Pediatric Institute
     CE: 0.00
  • Tuesday, Oct 28th
    10:00 AM - 11:30 AM Central Time
    28T26: Promoting Comparative Effectiveness Research in Pediatric Rheumatology: The Challenges of Making Consensus Treatment Plans Work
    Location: W471B
    Moderator: Emily von Scheven, MD – University of California, San Francisco
    Moderator: Emily Smitherman, MD, MS – University of Alabama at Birmingham
    Session Coordinator: Jessica Neely, MD – UCSF
     CE: 1.5
  • Tuesday, Oct 28th
    10:00 AM - 10:15 AM Central Time
    1740: A New Link Between Calprotectin, Cholesterol Efflux Dysfunction, and Premature Atherosclerosis in Juvenile Dermatomyositis
    Location: W196A-C
    Presenting Author: Emily Chong, BS – University of Michigan
     CE: 0.00
  • Tuesday, Oct 28th
    10:00 AM - 10:20 AM Central Time
    Implementation Science Methodology in Driving Comparative Effectiveness Research
    Location: W471B
    Speaker: Cagri Yildirim-Toruner, MD – Baylor College of Medicine/ Texas Children's Hospital
     CE: 1.5
  • Tuesday, Oct 28th
    10:15 AM - 10:30 AM Central Time
    1741: Chronic JDM Plasma Proteomic Signature Reflects Inflammation from Immune and Tissue-resident Muscle and Skin
    Location: W196A-C
    Presenting Author: Marianne Kerski, MD, BS (she/her/hers) – University of Michigan
     CE: 0.00
  • Tuesday, Oct 28th
    10:20 AM - 10:40 AM Central Time
    The CARRA Consensus Treatment Plan Program: A Critical Tool for Advancing Pediatric Rheumatology Research
    Location: W471B
    Speaker: Stacy Ardoin, MD;MSc – Nationwide Children's Hospital
     CE: 1.5
  • Tuesday, Oct 28th
    10:30 AM - 10:45 AM Central Time
    1742: S100B in Childhood-onset Systemic Lupus Erythematosus: Associations with Disease Features, Interferon Levels, and Cognitive Functioning
    Location: W196A-C
    Presenting Author: Ganesh Ramanathan, -None- – The Hospital for Sick Children
     CE: 0.00
  • Tuesday, Oct 28th
    10:40 AM - 11:00 AM Central Time
    Advancing Consensus Treatment to Improve Outcomes in JIA: Using Implementation Science
    Location: W471B
    Speaker: Stacey Tarvin, MD;MS;FACR – Riley Hospital for Children at Indiana University
     CE: 1.5
  • Tuesday, Oct 28th
    10:45 AM - 11:00 AM Central Time
    1743: Comparative assessment of cardiovascular risk and its predictors in a large cohort of young adults with juvenile systemic lupus erythematosus and juvenile dermatomyositis
    Location: W196A-C
    Presenting Author: Coziana Ciurtin, MD, PhD, FRCP – University College London
     CE: 0.00
  • Tuesday, Oct 28th
    11:00 AM - 11:15 AM Central Time
    1744: Preceding Mental Health Diagnosis Does Predict Eventual Neuropsychiatric Disease in Childhood-Onset Systemic Lupus Erythematosus
    Location: W196A-C
    Presenting Author: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Tuesday, Oct 28th
    11:00 AM - 11:30 AM Central Time
    Panel Discussion
    Location: W471B
    Panelist: Stacy Ardoin, MD;MSc – Nationwide Children's Hospital
    Panelist: Stacey Tarvin, MD;MS;FACR – Riley Hospital for Children at Indiana University
    Panelist: Cagri Yildirim-Toruner, MD – Baylor College of Medicine/ Texas Children's Hospital
     CE: 1.5
  • Tuesday, Oct 28th
    11:15 AM - 11:30 AM Central Time
    1745: High Emotional Distress Predicts Suboptimal Cardiovascular Health Among Patients with Juvenile-Onset Lupus and Dermatomyositis: Longitudinal Analysis of the Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Cohort Study
    Location: W196A-C
    Presenting Author: Kaveh Ardalan, MD, MS – Duke University School of Medicine
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Pediatric Rheumatology – Basic Science Poster
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Pediatric Rheumatology – Clinical Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2124: Reliability and Validation of the Physician's Global Assessment of Lung Disease (PGALD) in Systemic Juvenile Idiopathic Arthritis -Associated Lung Disease (SJIA-LD)
    Location: Hall F1
    Abstract Poster Presenter: Eileen Rife, MD – University of Alabama Birmingham
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2125: Development and Validation of Minimal Clinically Important Difference for Children with Chronic Nonbacterial Osteomyelitis Using a Consensus and Data-Driven Approach
    Location: Hall F1
    Abstract Poster Presenter: Farzana Nuruzzaman, MD – Stony Brook Children's Hospital
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2126: Preliminary Results of a Large, Global Registry Characterizing Childhood-Onset Takayasu Arteritis
    Location: Hall F1
    Abstract Poster Presenter: James Bistolarides, MD – Medical College of Wisconsin
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2127: Chronic Non-Bacterial Osteomyelitis of the Petrous Bone: A Case Series
    Location: Hall F1
    Abstract Poster Presenter: Jeanine McColl, MD – University of Calgary
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2127: Chronic Non-Bacterial Osteomyelitis of the Petrous Bone: A Case Series
    Location: Hall F1
    Abstract Poster Presenter: Jeanine McColl, MD – University of Calgary
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2128: Prevalence of Risks and Complications in a Longitudinal International Cohort of Children with Chronic Nonbacterial Osteomyelitis (CNO)
    Location: Hall F1
    Abstract Poster Presenter: Jessica Kent, MBA (she/her/hers) – Medical College of Wisconsin
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2129: Distinct endotypes of SURF associated with clinical phenotypes, inflammatory cytokines, and treatment responses
    Location: Hall F1
    Abstract Poster Presenter: Marci Macaraeg, MD, MSc – University of Arizona/Banner
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2130: Systemic juvenile idiopathic arthritis- Fifteen-year experience from a tertiary centre at Bristol, United Kingdom
    Location: Hall F1
    Abstract Poster Presenter: Ashwini Batchu Prithvi, MBBS, MD, MRCP – Bristol Royal Hospital for Children
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2131: Transition from Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype
    Location: Hall F1
    Abstract Poster Presenter: austen grooms, DO (he/him/his) – Beaumont Royal Oak
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2132: The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-To-Adult Rheumatology Transition Program, Reduces Median Time between Final Pediatric, First Adult, and Second Adult Visits
    Location: Hall F1
    Abstract Poster Presenter: Ayah Eltoum, MD, MPH – University of Alabama at Birmingham
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2133: Examination of HLA-DRB1*15-linked Candidate Antigens in Still’s Disease with and without Lung Disease and Features of Drug Hypersensitivity
    Location: Hall F1
    Abstract Poster Presenter: Dale Kobrin, MD – NIAMS, NIH
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2134: Krebs von den Lungen-6 (KL-6) as a Potential Diagnostic Biomarker of Lung Disease in Pediatric Systemic Juvenile Idiopathic Arthritis: Preliminary Findings from a Multisite US Cohort
    Location: Hall F1
    Abstract Poster Presenter: Eileen Rife, MD – University of Alabama Birmingham
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2135: Medication Use and Disease Activity in Systemic Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
    Location: Hall F1
    Abstract Poster Presenter: Ginger Janow, MD, MPH – Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2136: Confirming The Validity Of The New EULAR/ACR Classification Criteria For Pediatric Chronic Nonbacterial Osteomyelitis
    Location: Hall F1
    Abstract Poster Presenter: Greta Mastrangelo, MD (she/her/hers) – The Hospital for Sick Children
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2137: Therapeutic Strategies in Newly Diagnosed Still’s Disease: Real-Life Clinicians’ Choices from the METAPHOR Project Worldwide Survey
    Location: Hall F1
    Abstract Poster Presenter: Greta Rogani, MD – University Medical Center Utrecht
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2138: Factors driving therapeutic decision-making in Still’s Disease: When to Start and When to Stop? Data from the METAPHOR Project Worldwide Survey
    Location: Hall F1
    Abstract Poster Presenter: Greta Rogani, MD – University Medical Center Utrecht
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2139: Real-Life Treatment Strategies for Refractory Still’s Disease: Results from a Worldwide Survey, the METAPHOR Project
    Location: Hall F1
    Abstract Poster Presenter: Greta Rogani, MD – University Medical Center Utrecht
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2140: Identification of immune phenotypes in systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD) using high parameter flow cytometry
    Location: Hall F1
    Abstract Poster Presenter: Haeja Kessler, MD (she/her/hers) – Cincinnati Children's Hospital
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2141: Treatment of Refractory Still’s/Systemic Juvenile Idiopathic Arthritis Lung Disease with the bi-specific IL-1Beta/IL-18 neutralizing antibody MAS825
    Location: Hall F1
    Abstract Poster Presenter: Hallie Carol, MD (she/her/hers) – Children’s Hospital of Philadelphia
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2142: Multidisciplinary Rheumatology Transition Clinic for Young Adults Shows Improved Experience, Utilization, and Health Maintenance: A Mixed-Methods Evaluation
    Location: Hall F1
    Abstract Poster Presenter: Hannah Concannon, BS – Duke University School of Medicine
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2143: Ruxolitinib for Refractory sJIA/AOSD: A Single Center Case Series
    Location: Hall F1
    Abstract Poster Presenter: Janna Shim, DO – Kaiser Permanente San Jose
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2144: The Association Between Age at Diagnosis and Health-Related Quality of Life in ANCA-Associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Jessica Bloom, MD, MS – University of Colorado
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2145: EOS® Imaging System Is a Novel, Rapid, Safe, and Effective Technique To Detect And Assess Calcinosis In JDM
    Location: Hall F1
    Abstract Poster Presenter: Jessica Perfetto, MD – NYU
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2146: Impact of a Clinical Pathway on Medication Use and Outcomes in Kawasaki Disease
    Location: Hall F1
    Abstract Poster Presenter: Jonathan Yu, MD – Children's Hospital of Philadelphia
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2147: Elevated fMET and GDF-15 Circulating Levels in Pediatric CNO Patients with Psoriasis Define a Distinct Mitochondrial-Inflammatory Signature
    Location: Hall F1
    Abstract Poster Presenter: Jorge Gonzalez Chapa, MD, PhD – University of Washington
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2148: Initial MRI Findings as Predictors of Disease Phenotype in Juvenile Dermatomyositis: A Comparative Study of Myositis Specific Antibodies NXP2-Positive and Myositis Specific Antibody-Negative Patients in a Large Tertiary Hospital
    Location: Hall F1
    Abstract Poster Presenter: Juan Torres Sanchez, MD (he/him/his) – Baylor College of Medicine
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2149: Rheumatology Transitions of Care: Patient Stability and Follow-Up at a Single Center
    Location: Hall F1
    Abstract Poster Presenter: Julia Witowska, MD – University of Michigan
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2150: Rheum to Grow:An Approach Towards Human Centered Design through a Qualitative Analysis on the Transition from Pediatric to Adult Rheumatology
    Location: Hall F1
    Abstract Poster Presenter: Lillian Chang, MD – Geisinger Medical Center
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2151: Real-World Experience with IL-1 Blockade in Children with Undifferentiated Systemic Autoinflammatory Diseases (uSAIDs)
    Location: Hall F1
    Abstract Poster Presenter: Maryam Ashoor, MBBCH;BAO – Division of Immunology, Boston Children’s Hospital, Harvard Medical School
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2152: Blau Syndrome: features beyond the classic triad and proposal for clinical criteria
    Location: Hall F1
    Abstract Poster Presenter: Narendra Bagri, MD (he/him/his) – All India Institute of Medical Sciences(AIIMS)
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2153: Giant Coronaries in Children with Kawasaki Disease: A Single Centre Experience
    Location: Hall F1
    Abstract Poster Presenter: Pavneet Kaur, MBBS, MD – All India Institute of Medical Sciences, New Delhi
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2154: Whole-Body MRI Findings in a Cohort of  Children with Chronic Nonbacterial Osteomyelitis
    Location: Hall F1
    Abstract Poster Presenter: Sampath Prahalad, MD, MSc – Emory + Children's Pediatric Institute
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2155: A Novel TNFAIP3 Mutation Associated with Large Vessel Vasculitis: Expanding the Phenotypic Spectrum of A20 Haploinsufficiency
    Location: Hall F1
    Abstract Poster Presenter: Sirada Panupattanapong, MD, RhMSUS – Cleveland Clinic Foundation
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2156: Bridging the Gap: Juvenile Spondyloarthritis (JSpA) vs. Chronic Non-bacterial Osteomyelitis (CNO)
    Location: Hall F1
    Abstract Poster Presenter: Sophia Elfrink, BA – Grinnell College
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2157: Optimizing the Diagnosis and Treatment of Kawasaki Disease-Associated Macrophage Activation Syndrome: A Clinical Cohort and Literature Analysis
    Location: Hall F1
    Abstract Poster Presenter: Xi Yang, MD – Department of Rheumatology & Immunology, Children’s Hospital of Chongqing Medical University
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2158: Evaluating Nailfold Capillary Changes as Indicators of Disease Activity in Juvenile Dermatomyositis
    Location: Hall F1
    Abstract Poster Presenter: Zilan Zheng, BS, CCRP – University of California, San Francisco
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1809: Mass Spectrometry-Based N-Terminomics Uncovers Proteolytic Signatures and Pathways in Juvenile Idiopathic Arthritis Synovial Fluid
    Location: Hall F1
    Abstract Poster Presenter: Andrew Zeft, MD, MPH – Cleveland Clinic
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1822: The Circulating Immune Profile of Systemic JIA Patients with HLA-DRB1*15 alleles, Eosinophilia, and Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Jennifer Cheng, BA – Boston Children's Hospital
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1819: Spatial Transcriptomic Profiling Reveals Interferon Activation and CD8⁺ T Cell Dominance in Systemic Juvenile Idiopathic Arthritis-Macrophage Activation Syndrome Liver Inflammation
    Location: Hall F1
    Abstract Poster Presenter: Esraa Eloseily, MD, MSc – UT Southwestern Children's Medical Center
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1820: Cytokine profiling in refractory systemic juvenile idiopathic arthritis reveals distinct signatures for macrophage activation syndrome and lung disease.
    Location: Hall F1
    Abstract Poster Presenter: Grant Schulert, MD, PhD – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1823: Genome-Wide DNA Methylation Analysis in Familial Mediterranean Fever
    Location: Hall F1
    Abstract Poster Presenter: Kader Cetin Gedik, MD – UPMC Children's Hospital of Pittsburgh/University of Pittsburgh
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1827: Transcriptomics and Machine Learning Unraveling the Molecular Drivers of PFAPA Flares
    Location: Hall F1
    Abstract Poster Presenter: Sivia Lapidus, MD – Hackensack University Medical Center
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1826: Single Nuclei Multiome of JDM Muscle Biopsies Reveals Novel Upregulation of Inflammatory and Vascular Pathways
    Location: Hall F1
    Abstract Poster Presenter: Shannon O'Connor, MD, PhD – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1824: Tissue-Resident Natural Killer Cells May Drive Monocyte Differentiation And Macrophage Accumulation In The Inflamed Joints Of Pediatric Juvenile Idiopathic Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Roselyn Fierkens, BS – University of Colorado-Anschutz Medical Campus
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1828: CD14+CXCL10+Monocytes Remodel the Peripheral Immune Network in sJIA via UBE2D1-Driven Inflammatory Programming
    Location: Hall F1
    Abstract Poster Presenter: Xuemei Tang, MD, Professor, Chief Physician – Department of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1815: New-Onset Juvenile Spondyloarthritis is Characterized by Bone Metabolism Disturbances with Biomarker Potential
    Location: Hall F1
    Abstract Poster Presenter: Brittney Newby, MD;PhD (she/her/hers) – Children's Hospital of Philadelphia
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1813: Frequency of Tissue-Specific Activated CD8+ T Cells is Correlated To Disease Severity in Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Abigail Thielbar, BS – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1812: Inflammasome and UPR activation in monocytes of HLA B27 positive children with Enthesitis related arthritis category of JIA
    Location: Hall F1
    Abstract Poster Presenter: Shivika Guleria, MSc – SGPGIMS, Lucknow
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1829: Multiomic Investigation of Juvenile Idiopathic Arthritis Synovium Reveals Immune Cell Heterogeneity
    Location: Hall F1
    Abstract Poster Presenter: Yuriy Baglaenko, PhD – Cincinnati Children's Hospital
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1814: Trapped in the NET: Impaired DNase function and targeted antibodies in the pathogenesis of pediatric lupus nephritis
    Location: Hall F1
    Abstract Poster Presenter: Bharati Matta, PhD, MBA – The Feinstein Institutes for Medical Research
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1811: Pharmacogenomic analysis of prediction of IL-1 Inhibitor treatment response in the CARRA First-line Options for Systemic Juvenile Idiopathic Arthritis Treatment (FROST) Study
    Location: Hall F1
    Abstract Poster Presenter: Mariana Correia Marques, MD – National Institutes of Health
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1810: Destabilized Treg Cells Predominant in Severe Forms of Juvenile Idiopathic Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Ki Pui Lam, PhD – Division of Immunology, Boston Childrens Hospital, Harvard Medical School
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1818: Epigenetic Profiling of Childhood-onset Lupus Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Drivers of Disease Activity
    Location: Hall F1
    Abstract Poster Presenter: Desire Casares Marfil, PhD – School of Medicine, University of Pittsburgh
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1817: Sex-specific mechanisms associated with female childhood-onset systemic lupus erythematosus revealed by transcriptomic analysis of transgender adolescents undergoing gender-affirming sex hormone therapy.
    Location: Hall F1
    Abstract Poster Presenter: Coziana Ciurtin, MD, PhD, FRCP – University College London
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1825: Serum proteomic and single cell RNA sequencing analysis reveals macrophage activation syndrome physiology and widespread complement dysregulation are associated with severe dengue infection in a pediatric cohort
    Location: Hall F1
    Abstract Poster Presenter: Sarah McCuaig, MD, PhD (she/her/hers) – Children's Hospital of Philadelphia
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1816: Single-Cell RNA-Transcriptomics of JDM Skin Identifies JDM-Associated Immune Cell Populations and Dysregulated Interferon Signaling in Immune and Endothelial Cells
    Location: Hall F1
    Abstract Poster Presenter: Chioma Madubata, MD, PhD – UCSF
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1821: Transcriptiomics of tear RNA from children with active and inactive chronic anterior uveitis
    Location: Hall F1
    Abstract Poster Presenter: Grant Schulert, MD, PhD – Cincinnati Children's Hospital Medical Center
     CE: 0.00
  • Tuesday, Oct 28th
    1:00 PM - 2:00 PM Central Time
    28T47: Charting the Path Forward: 2024 DRAFT Updates to ACR JIA Guidelines
    Location: W471B
    Moderator: Daniel Lovell, MD, MPH – Cincinnati Children's Hospital Medical Center
    Moderator: Richard K. Vehe, MD – None
     CE: 1
  • Tuesday, Oct 28th
    1:00 PM - 1:10 PM Central Time
    Laying the Foundation: Overview of the New ACR JIA Guidelines
    Location: W471B
    Speaker: Karen Onel, MD – HSS
     CE: 1
  • Tuesday, Oct 28th
    1:10 PM - 1:20 PM Central Time
    Systemic JIA Guideline Updates
    Location: W471B
    Speaker: Susan Shenoi, MS, MBBS, RhMSUS – Seattle Children's Hospital and Research Center
     CE: 1
  • Tuesday, Oct 28th
    1:20 PM - 1:30 PM Central Time
    Non-Systemic JIA Guideline Updates
    Location: W471B
    Speaker: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
     CE: 1
  • Tuesday, Oct 28th
    1:30 PM - 1:40 PM Central Time
    JIA-Associated Uveitis Guideline Updates
    Location: W471B
    Speaker: Sheila Angeles-Han, MD, MSc – Cincinnati Children's Hospital
     CE: 1
  • Tuesday, Oct 28th
    1:40 PM - 2:00 PM Central Time
    Q and A
    Location: W471B
    Speaker: Susan Shenoi, MS, MBBS, RhMSUS – Seattle Children's Hospital and Research Center
    Speaker: Karen Onel, MD – HSS
    Speaker: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
     CE: 1
  • Tuesday, Oct 28th
    4:00 PM - 5:00 PM Central Time
    28T67: Eyes on the Spine: Therapeutic Decisions for Pediatric Sacroiliitis Through the Life Span
    Location: W185A-D
    Moderator: Hemalatha Srinivasalu, MD, MBBS – Children's National Hospital
    Moderator: Philip Hashkes, MD, RhMSUS, MSc – Shaare Zedek Medical Center
    Session Coordinator: Jaime Guzman, MD, MSc – University of British Columbia and BC Children's Hospital
     CE: 1
  • Tuesday, Oct 28th
    4:00 PM - 5:00 PM Central Time
    28T68: Cracking the Code: Overcoming the Challenges in Kawasaki Disease Treatment
    Location: W471B
    Moderator: Olha Halyabar, MD – Children's Hospital/Boston Medical Center
    Moderator: Anita Dhanrajani, MBBS, MSc – Manning Family Children's Hospital, Tulane School of Medicine
    Session Coordinator: Pui Lee, MD, PhD – Boston Children's Hospital
     CE: 1
  • Tuesday, Oct 28th
    4:00 PM - 5:00 PM Central Time
    NL28T7: Pediatric Rheumatology: Best Practices and Idea Exchange for Pediatric Rheumatology Resident Rotations
    Location: W470B
    Lead Facilitator: Julia Shalen, MD – Johns Hopkins University
     CE: 0
  • Tuesday, Oct 28th
    4:00 PM - 4:30 PM Central Time
    Beyond IVIG Treatment Strategies for Refractory KD
    Location: W471B
    Speaker: Rae Yeung, MD, PhD – The Hospital for Sick Children, University of Toronto
     CE: 1
  • Tuesday, Oct 28th
    4:00 PM - 4:30 PM Central Time
    Challenges in Defining and Monitoring Pediatric Sacroiliitis via Imaging
    Location: W185A-D
    Speaker: Walter P P. Maksymowych, MD, FRCPC, MRCP, FACP – University of Alberta
     CE: 1
  • Tuesday, Oct 28th
    4:30 PM - 5:00 PM Central Time
    Defining Who Needs to Get What: Risk Stratification in Kawasaki Disease Treatment
    Location: W471B
    Speaker: Mary Beth Son, MD – Boston Children's Hospital
     CE: 1
  • Tuesday, Oct 28th
    4:30 PM - 5:00 PM Central Time
    When to Start and When to Stop: Treatment Decisions in Pediatric Sacroiliitis
    Location: W185A-D
    Speaker: Pamela Weiss, MD – Childrens Hospital of Philadelphia
     CE: 1
  • Wednesday, Oct 29th
    11:30 AM - 1:00 PM Central Time
    29W17: Abstracts: Pediatric Rheumatology – Clinical III
    Location: W196A-C
    Abstract Moderator: Katherine Marzan, MD – Children's Hospital Los Angeles
    Abstract Moderator: Sangeeta Sule, MD, PhD – Children's National Hospital
     CE: 0.00
  • Wednesday, Oct 29th
    11:30 AM - 11:45 AM Central Time
    2675: RANTES and CXCL10 as Potential Tear-Based Biomarkers Associated with Ocular Damage in Pediatric Chronic Anterior Uveitis
    Location: W196A-C
    Presenting Author: Ilaria Maccora, MD, PhD (she/her/hers) – Rheumatology Unit, ERN ReCoNNET Center, Meyer Children's Hospital IRCCS, Florence, Italy
     CE: 0.00
  • Wednesday, Oct 29th
    11:45 AM - 12:00 PM Central Time
    2676: Tofacitinib in Juvenile spondyloarthropathy: clinical efficacy, impact on biomarkers and comparison with Adalimumab
    Location: W196A-C
    Presenting Author: Amita Aggarwal, MD, MBBS, DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
     CE: 0.00
  • Wednesday, Oct 29th
    12:00 PM - 12:15 PM Central Time
    2677: Quantified Imaging Response at the Sacroiliac Joints to TNF-Inhibitor Therapy in Youth with Axial Disease
    Location: W196A-C
    Presenting Author: Timothy Brandon, MPH – Children's Hospital of Philadelphia
     CE: 0.00
  • Wednesday, Oct 29th
    12:15 PM - 12:30 PM Central Time
    2678: The Association Between Medication Taper Duration and Time to JIA Disease Flare: A Retrospective Cohort Study
    Location: W196A-C
    Presenting Author: Christian-Immanuel Oliveros, MD – University of Florida
     CE: 0.00
  • Wednesday, Oct 29th
    12:30 PM - 12:45 PM Central Time
    2679: Early-Life Nutrition and Gene-Environment Interactions Influencing Juvenile Idiopathic Arthritis Risk: Results from a Pregnancy Cohort
    Location: W196A-C
    Presenting Author: Vilde Øverlien Dåstøl, MD – Oslo University Hospital
     CE: 0.00
  • Wednesday, Oct 29th
    12:45 PM - 1:00 PM Central Time
    2680: High Health Care Utilization Preceding Diagnosis of Juvenile Idiopathic Arthritis
    Location: W196A-C
    Presenting Author: Anna Costello, MD, RhMSUS (she/her/hers) – Children's Hospital of Philadelphia
     CE: 0.00